Canopy Growth Corp
CGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001737927
In the last 90 days, Canopy Growth Corp insiders filed 0 open-market purchases and 5 sales; 218 institutions reported holding it in 13F filings for Q2 2026, worth $28.3M in total; no superinvestor holds it.
- Currency
- CAD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:57 PM ET
Amounts are in CAD, the currency Canopy Growth Corp reports in. Lines marked ≈ US$ convert key figures to US dollars.
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2026: CAD 262.9M (92.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jun 15, 2026 | May 30, 2025 | May 30, 2024 | Jun 22, 2023 | Apr 29, 2022 |
| Revenue | CAD 284.6M≈ US$206.0M | CAD 269.0M≈ US$193.5M | CAD 297.1M≈ US$220.4M | CAD 402.9M≈ US$304.8M | CAD 520.3M≈ US$415.2M |
| Cost of revenue | CAD 214.9M | CAD 189.5M | CAD 216.3M | CAD 507.0M | CAD 713.4M |
| Gross profit | CAD 69.7M | CAD 79.5M | CAD 80.9M | CAD -104.1M | CAD -193.1M |
| Operating expenses | CAD 231.3M | CAD 196.7M | CAD 309.6M | CAD 2.74B | CAD 889.6M |
| Research and development | CAD 2.61M | CAD 2.74M | CAD 4.61M | CAD 21.7M | CAD 32.3M |
| Selling, general and administrative | CAD 160.0M | CAD 169.6M | CAD 229.4M | CAD 456.2M | CAD 472.8M |
| Operating income | CAD -161.7M | CAD -117.1M | CAD -228.7M | CAD -2.85B | CAD -1.08B |
| Interest expense | CAD 38.2M | CAD 74.6M | CAD 105.4M | CAD 126.2M | CAD 103.9M |
| Income tax | CAD 23.0K | CAD 7.14M | CAD 12.3M | CAD -4.77M | CAD -8.95M |
| Net income | CAD -262.9M≈ US-$190.3M | CAD -598.1M≈ US-$430.2M | CAD -657.3M≈ US-$487.5M | CAD -3.28B≈ US-$2.48B | CAD -302.2M≈ US-$241.1M |
| EPS, basic | CAD -0.88 | CAD -5.56 | CAD -8.79 | CAD -7.07 | – |
| EPS, diluted | CAD -0.88 | CAD -5.56 | CAD -8.79 | CAD -7.07 | – |
| Weighted shares, basic | 298.0M | 107.6M | 74.8M | 463.7M | – |
| Weighted shares, diluted | 298.0M | 107.6M | 74.8M | 463.7M | – |
| Margins and growth | |||||
| Gross margin | 24.5% | 29.6% | 27.2% | -25.8% | -37.1% |
| Operating margin | -56.8% | -43.5% | -77.0% | -706.9% | -208.1% |
| Net margin | -92.4% | -222.4% | -221.2% | -813.6% | -58.1% |
| Revenue growth, year over year | +5.8% | −9.5% | −26.2% | −22.6% | −4.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jun 15, 2026 | May 30, 2025 | May 30, 2024 | Jun 22, 2023 | Apr 29, 2022 |
| Cash and equivalents | CAD 364.7M | CAD 113.8M | CAD 170.3M | CAD 677.0M | CAD 776.0M |
| Short-term investments | CAD 0 | CAD 17.7M | CAD 33.2M | CAD 105.6M | CAD 595.7M |
| Accounts receivable | CAD 31.2M | CAD 47.5M | CAD 44.9M | CAD 66.8M | CAD 78.1M |
| Inventory | CAD 110.5M | CAD 96.4M | CAD 77.3M | CAD 148.9M | CAD 204.4M |
| Total current assets | CAD 529.5M | CAD 294.6M | CAD 371.2M | CAD 1.08B | CAD 1.74B |
| Property, plant and equipment | CAD 316.5M | CAD 293.5M | CAD 320.1M | CAD 499.5M | CAD 942.8M |
| Goodwill | CAD 55.7M | CAD 46.0M | CAD 43.2M | CAD 85.6M | CAD 1.87B |
| Intangible assets | CAD 92.4M | CAD 87.2M | CAD 104.1M | CAD 188.7M | CAD 252.7M |
| Total assets | CAD 1.12B≈ US$801.8M | CAD 917.7M≈ US$638.2M | CAD 1.30B≈ US$960.4M | CAD 2.44B≈ US$1.80B | CAD 5.62B≈ US$4.50B |
| Accounts payable | CAD 34.8M | CAD 26.1M | CAD 28.7M | CAD 76.2M | CAD 64.3M |
| Short-term debt | CAD 16.2M | CAD 4.26M | CAD 103.9M | CAD 556.9M | CAD 9.30M |
| Total current liabilities | CAD 158.4M | CAD 94.4M | CAD 234.7M | CAD 803.8M | CAD 212.9M |
| Long-term debt | CAD 217.1M | CAD 299.8M | CAD 493.3M | CAD 750.0M | CAD 1.49B |
| Total liabilities | CAD 421.1M | CAD 430.5M | CAD 799.8M | CAD 1.68B | CAD 1.98B |
| Shareholders' equity | CAD 697.6M | CAD 487.2M | CAD 500.5M | CAD 760.0M | CAD 3.59B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jun 15, 2026 | May 30, 2025 | May 30, 2024 | Jun 22, 2023 | Apr 29, 2022 |
| Operating cash flow | CAD -63.8M≈ US-$46.2M | CAD -165.8M≈ US-$119.2M | CAD -281.9M≈ US-$209.1M | CAD -557.5M≈ US-$421.8M | CAD -545.8M≈ US-$435.5M |
| Capital expenditures | CAD 5.33M | CAD 10.8M | CAD 3.45M | CAD 9.22M | CAD 36.7M |
| Free cash flow | CAD -69.1M≈ US-$50.0M | CAD -176.6M≈ US-$127.0M | CAD -285.4M≈ US-$211.7M | CAD -566.8M≈ US-$428.8M | CAD -582.5M≈ US-$464.8M |
| Stock-based compensation | CAD 4.27M | CAD -4.21M | CAD 14.2M | CAD 31.2M | CAD 47.5M |
| Investing cash flow | CAD -21.3M | CAD -47.8M | CAD 241.6M | CAD 433.4M | CAD 230.8M |
| Financing cash flow | CAD 332.4M | CAD 148.7M | CAD -465.1M | CAD -19.7M | CAD -45.5M |
| Net change in cash | CAD 250.9M | CAD -56.5M | CAD -506.7M | CAD -99.0M | CAD -378.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.5% | -1.6% | 4.8% | 7.7% | 9.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 4, 2026 | 423.4M | +23.7% | SEC |
| Aug 5, 2026 | 423.0M | +76.4% | SEC |
| Jun 11, 2026 | 422.2M | +128.0% | SEC |
| Feb 5, 2026 | 377.9M | +156.8% | SEC |
| Nov 6, 2025 | 342.2M | +224.8% | SEC |
| Aug 7, 2025 | 239.8M | +182.7% | SEC |
| May 28, 2025 | 185.2M | +143.0% | SEC |
| Feb 6, 2025 | 147.1M | +61.5% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- ≈ US$ figures convert CAD at FRED H.10 exchange rates (Federal Reserve): the average rate over the period for income and cash flow, and the rate on the period-end date, or the last business day before it, for the balance sheet.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Mar 31, 2021, from 13F share counts: 1-for-10 in Q4 2023.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.